Commonly used prostate cancer treatment rewires engine of prostate tumors: Research Isra Zaman16 Sept 2022 9:15 AM ISTDrugs like enzalutamide that inhibit male hormones from activating the androgen receptor have been used to treat advanced prostate cancer for more...
Low testosterone levels tied to increased COVID-19 hospitalization risk among men Dr. Kamal Kant Kohli5 Sept 2022 9:30 AM ISTAccording to a new study by researchers at Washington University School of Medicine in St. Louis and Saint Louis University School of Medicine. low...
Therapy to improve cognitive function in Down syndrome patients Isra Zaman2 Sept 2022 9:00 AM ISTIn a study, the researchers sought to determine whether GnRH injection therapy was effective in enhancing the cognitive abilities of a small group of...
In cystic fibrosis patients Infusion of GLP-1 improves function of impaired islet cells in pancreas Dr. Kamal Kant Kohli17 Aug 2022 10:15 AM ISTCystic fibrosis is well-known for attacking the lungs through thick blockages of mucus, but those with the condition often also develop diabetes...
Prasterone shows promise in reducing severity of urinary urge incontinence Dr. Kamal Kant Kohli5 Aug 2022 7:00 PM ISTBecause of a decrease in estrogen, menopause is often accompanied by multiple vaginal and urinary issues. To date, most treatment options focus on...
Hormone therapy for prostate cancer increases mortality risk due to cardiovascular disease Dr. Kamal Kant Kohli1 Aug 2022 7:45 PM ISTHormone therapy for prostate cancer increases the risk of cardiovascular disease-related death especially in older men, according to a population...
Hormone replacement therapy doesn't lead to breast cancer recurrence Dr. Kamal Kant Kohli21 July 2022 7:30 PM ISTA new paper in the Journal of the National Cancer Institute, published by Oxford University Press, finds that menopausal hormone therapy for breast...
Hormone Therapy Position Statement 2022 released by NAMS Dr. Kamal Kant Kohli10 July 2022 7:45 PM ISTCLEVELAND, Ohio: In the 20 years since the Women's Health Initiative, hormone therapy remains one of the most hotly debated topics around the...
Fezolinetant reduces frequency and severity of menopausal hot flashes, finds Phase 3 study Dr. Kamal Kant Kohli24 Jun 2022 11:00 AM ISTATLANTA: Fezolinetant significantly reduced the frequency and severity of moderate-to-severe vasomotor symptoms (VMS), or hot flashes, associated with...
HRT remains most effective treatment for menopause symptoms of hot flashes and night sweats Dr. Kamal Kant Kohli3 Jun 2022 7:45 PM ISTCLEVELAND, Ohio: It has been 20 years since The Women's Health Initiative suggested a link between hormone therapy (HT) and increased risks for breast...
Common prostate cancer medications may be less safe than previously thought Dr. Kamal Kant Kohli1 Jun 2022 8:00 PM ISTMen taking either of the two most common oral medications for advanced prostate cancer who had also undergone hormone therapy to treat their disease...
Levels of anti-Mullerian hormone could predict bone loss in postmenopausal women Dr. Kamal Kant Kohli7 April 2022 10:30 PM ISTPhysicians may be able to determine if menopause-related bone loss is already in progress or about to begin by measuring the level of a hormone that...
